OPTIMIZE CEFEPIME DOSING IN CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS VENOVENOUS HEMOFILTRATION

被引：0
|
作者：
Lin, Hsin [1 ]
Boidin, Clement [2 ]
Evans, Danielle
Lopez, Natasha [3 ]
Healy, Daniel [4 ]
Serpico, Elena [3 ]
Goutelle, Sylvain [5 ]
Roberts, Jason [6 ]
机构：
[1] Taipei Med Univ Hosp, Taipei, MA, Taiwan
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Cincinnati, Cincinnati, OH USA
[5] Hosp Pierre Garraud, Lyon, France
[6] Univ Queensland, Brisbane, Qld, Australia
来源：
CRITICAL CARE MEDICINE | 2019年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
610
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
    Leung, Anne Kit-Hung
    Shum, Hoi-Ping
    Chan, King-Chung
    Chan, Stanley Choi-Hung
    Lai, Kang Yiu
    Yan, Wing-Wa
    CRITICAL CARE RESEARCH AND PRACTICE, 2013, 2013
  • [42] Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis
    Shotwell, Matthew S.
    Madonia, Phillip N.
    Connor, Michael J.
    Amde, Milen
    Salem, Charbel
    Aduroja, Olufemi A.
    Bauer, Seth R.
    Groszek, Joseph J.
    Fissell, William H.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (01) : 173 - 175
  • [43] Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration
    Tegeder, I
    Neumann, F
    Bremer, F
    Brune, K
    Lötsch, J
    Geisslinger, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (01) : 50 - 57
  • [44] Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding
    Palsson, R
    Niles, JL
    KIDNEY INTERNATIONAL, 1999, 55 (05) : 1991 - 1997
  • [45] Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen
    Georges, B
    Conil, JM
    Cougot, P
    Decun, JF
    Archambaud, M
    Seguin, T
    Chabanon, G
    Virenque, C
    Houin, G
    Saivin, S
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (08) : 360 - 369
  • [46] ASSESSING DIGOXIN DOSING IN PATIENTS UNDERGOING CONTINUOUS VENOVENOUS HEMOFILTRATION
    Allen, Erica
    Feih, Joel
    Juul, Janelle
    Cooper-Johnson, Kaitlin
    Herrmann, David
    Biggs, Adam
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 441 - 441
  • [47] Continuous venovenous hemofiltration versus continuous venovenous hemodiafiltration in critically ill patients: A retrospective cohort study from a Canadian tertiary centre
    AlEnezi, Farhan
    Alhazzani, Waleed
    Ma, Jinhui
    Alanazi, Safug
    Salib, Mary
    Attia, Menat
    Thabane, Lehana
    Fox-Robichaud, Alison
    CANADIAN RESPIRATORY JOURNAL, 2014, 21 (03) : 176 - 180
  • [48] Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
    Peng, Lengyue
    Gao, Yawen
    Zhang, Guangli
    Tian, Xiaoyin
    Xu, Huiting
    Yu, Qinghong
    Cheng, Jie
    Li, Yuanyuan
    Li, Qinyuan
    Chen, Yingfu
    Zhao, Wei
    Luo, Zhengxiu
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [49] Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
    Oliver, Wesley D.
    Heil, Emily L.
    Gonzales, Jeffrey P.
    Mehrotra, Shailly
    Robinett, Kathryn
    Saleeb, Paul
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1899 - 1901
  • [50] VANCOMYCIN PHARMACOKINETICS IN CRITICALLY ILL PATIENTS DURING ACCELERATED VENOVENOUS HEMOFILTRATION
    Lopez, Natasha
    Sin, Jonathan
    Griggs, Michael
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 440 - 440
12345